Balasubramaniam K, Wiesner R H, LaRusso N F
Division of Gastroenterology and Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Gastroenterology. 1988 Nov;95(5):1395-8. doi: 10.1016/0016-5085(88)90378-2.
We report 12 cases of primary sclerosing cholangitis (confirmed by cholangiography) in which the serum alkaline phosphatase activity was normal. The enzyme activity remained normal during follow-up in 7 cases and fluctuated in 5 cases (it returned to normal in 4). The presence of advanced histologic stage (fibrosis/cirrhosis) with marked cholangiographic changes in 4 patients establishes that cirrhotic-stage primary sclerosing cholangitis can occur without a concomitant increase in serum alkaline phosphatase activity. Therefore, primary sclerosing cholangitis may exist in an occult state without symptoms or increase in serum alkaline phosphatase activity. Our findings suggest that primary sclerosing cholangitis may be more prevalent than realized, especially in patients who have inflammatory bowel disease. A normal value for serum alkaline phosphatase activity should not preclude further investigation for primary sclerosing cholangitis in patients with inflammatory bowel disease when symptoms or signs suggest liver disease.
我们报告了12例经胆管造影确诊的原发性硬化性胆管炎患者,其血清碱性磷酸酶活性正常。7例患者在随访期间酶活性保持正常,5例波动(4例恢复正常)。4例患者存在晚期组织学阶段(纤维化/肝硬化)且胆管造影有明显改变,这表明肝硬化期原发性硬化性胆管炎可在血清碱性磷酸酶活性未同时升高的情况下发生。因此,原发性硬化性胆管炎可能以隐匿状态存在,无症状或血清碱性磷酸酶活性无升高。我们的研究结果表明,原发性硬化性胆管炎可能比人们意识到的更为普遍,尤其是在患有炎症性肠病的患者中。当有症状或体征提示肝脏疾病时,血清碱性磷酸酶活性正常的值不应排除对炎症性肠病患者进行原发性硬化性胆管炎的进一步检查。